The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids.
about
Emerging concepts in alcoholic hepatitisDiagnosis of alcoholic liver disease.Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.Fibroblast growth factor inducible 14 as potential target in patients with alcoholic hepatitisFocus on alcoholic liver disease: from nosography to treatment.Alcoholic hepatitis: current challenges and future directions.Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial.Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study.Alkaline phosphatase: the next independent predictor of the poor 90-day outcome in alcoholic hepatitisKASL clinical practice guidelines: management of alcoholic liver diseasePractical Concerns and Controversies in the Management of Alcoholic Hepatitis.Pharmacotherapy of acute alcoholic hepatitis in clinical practice.The management of alcoholic hepatitis.Pathophysiology and Management of Alcoholic Liver Disease: Update 2016.Alcoholic hepatitis: diagnosis and management in 2012.Prognosis and treatment of patients with acute alcoholic hepatitis.Alcoholic hepatitis: current management.Gamma Delta T-lymphocytes in Hepatitis C and Chronic Liver Disease.Prognostic models for alcoholic hepatitis.Diagnosis and treatment of alcoholic hepatitis.Acute Alcoholic Hepatitis, the Clinical Aspects.Medical Management of Severe Alcoholic Hepatitis: Expert Review from the Clinical Practice Updates Committee of the AGA Institute.Review article: recent insights into clinical decision-making in severe alcoholic hepatitis."Pseudotumoral" hepatic pattern in acute alcoholic hepatitis: a case report.The management of alcoholic hepatitis: a prospective comparison of scoring systems.Determinants of long-term outcome in severe alcoholic hepatitis.Clinical trials and their translation in hepatology: past, present, and future.Validation of prognostic scores for clinical use in patients with alcoholic hepatitis.Alcoholic liver disease
P2860
Q30234425-2A776C18-557F-4076-909B-654DE7FCD3DDQ30431186-06BA3DF8-1837-4122-8FC5-F6EAA1E39B55Q33587538-0DDA4E50-763F-43DA-86FA-6134BDBAD233Q33829369-3D7B549D-D5B5-4173-BA80-3B2ED2F45F41Q33845458-A7F38210-9EC9-4F66-A350-5C86719E45CDQ34354286-2FCB8BD0-267C-45FE-88EE-A93BF9E58BA0Q34973715-6BEBF415-64E2-484A-969D-FA6C94E78679Q35442766-27DFCF20-81CD-4C84-A013-976E89BE74CCQ37212281-417E167F-8275-419B-8ED4-30DB940640C6Q37229858-3B12B8DD-190E-4F92-95BA-EC3188A96572Q37421502-01AA34F5-9BAC-48EC-873F-561D00FA87C1Q37617944-89B535F2-52C8-498C-995D-371D3D4747C5Q37676833-C6BA28B2-805C-4A81-B09E-B637FB6563C7Q37696026-FEB20747-4662-4D5F-B8F3-2B6D9EDC0A46Q38067131-395C23B1-1D50-4642-9491-71E54BFD44ECQ38203313-86B9CEC7-617C-42C3-94C0-737FB80B7CF9Q38209601-AE1020ED-32F4-4953-974C-C7DA88E9AF6AQ38247990-153F43EC-9BCA-43A0-8894-71A5B3A7F342Q38552579-2CDEA2EB-FB23-4B6B-A0D2-77FB8A2DF666Q38609032-479091F8-3D9E-47EC-9AAB-827472A7CB94Q38884700-3207F765-4935-4D1C-AECD-36A344421837Q39039575-E6C4E0D6-A68D-47ED-BEEC-A82ADF817D6CQ39329505-BC0B5663-A860-44D9-AFA2-A0E6E7796DC6Q43064060-9B50ED02-D90C-40BF-B6BC-BE103A9FA85BQ44131679-0939F85E-FEF9-4F9D-8A6C-5DC560D11428Q44631715-9D87A011-19F8-4E52-86DB-AA4C16A09A52Q51643325-D8812AF6-A534-4AE9-A9D0-7D64487BD3C4Q53153419-52E05304-7ADC-4A21-BF0D-4644F3EC3FC9Q56004976-6E1D6FED-E7C2-44D9-B3D2-B397F1BBAF71
P2860
The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The Glasgow alcoholic hepatiti ...... benefit from corticosteroids.
@en
type
label
The Glasgow alcoholic hepatiti ...... benefit from corticosteroids.
@en
prefLabel
The Glasgow alcoholic hepatiti ...... benefit from corticosteroids.
@en
P2093
P2860
P356
P1433
P1476
The Glasgow alcoholic hepatiti ...... benefit from corticosteroids.
@en
P2093
A J Morris
E H Forrest
M Phillips
N C Fisher
P2860
P304
P356
10.1136/GUT.2006.099226
P407
P577
2007-07-12T00:00:00Z